Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Aveo

India bans drugs blamed for opioid crisis in West Africa

Aveo Pharmaceuticals is accused of illegally exporting banned combination of tapentadol and carisoprodol to Nigeria, Ghana and Ivory Coast

The Independent UK

Complete Exit For Exxon From Russia, Microsoft's Layoffs, Another Setback For Boeing's Potential 737 MAX 7 Approval, Visa & Mastercard Under FTC Probe: Top Stories Tuesday, Oct. 18

Complete Exit For Exxon From Russia, Microsoft's Layoffs, Another Setback For Boeing's Potential 737 MAX 7 Approval, Visa & Mastercard Under FTC Probe: Top Stories Tuesday, Oct. 18

Reuters Exxon Exits Russia Completely After Putin Seizes Company's Properties

Looking Into AVEO Pharmaceuticals's Return On Capital Employed

Looking Into AVEO Pharmaceuticals's Return On Capital Employed

AVEO Pharmaceuticals (NASDAQ:AVEO) brought in sales totaling $20.92 million during Q1 according to data provided by Benzinga Pro. However, earnings decreased 40.58%, resulting in a loss of $10.20 million.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Recap: AVEO Pharmaceuticals Q1 Earnings

AVEO Pharmaceuticals (NASDAQ:AVEO) reported its Q1 earnings results on Thursday, May 5, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Earnings Preview: AVEO Pharmaceuticals

AVEO Pharmaceuticals (NASDAQ:AVEO) is set to give its latest quarterly earnings report on Thursday, 2022-05-05. Here's what investors need to know before the announcement. Analysts estimate that AVEO Pharmaceuticals will report an earnings per share (EPS) of $-0.25.

AVEO Pharmaceuticals Earnings Conference Call Is Coming Up, Here's What You Need To Know

AVEO Pharmaceuticals (NASDAQ:AVEO) will host a conference call at 08:30 AM ET on May 5, 2022, to discuss Q1 2022 earnings results.

1

People

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

Lockheed Martin

Johnson & Johnson (

inkl

Read news from The Economist, FT, and more,
with one subscription

Places

360,378 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play